drugset / Trial / NCT00792168

Physiologic Monitoring of Antidepressant Response

NCT00792168

Phase 4 Completed 38 enrolled University of California, Los Angeles
RandomizedParallel-groupDouble-blindTreatment

Summary

Primary: to identify physiologic indicators of venlafaxine treatment response using quantitative EEG (QEEG) cordance, and to determine if cordance changes are specifically associated with response to venlafaxine; Secondary: to determine if cordance changes early in the course (i.e., prior to improvement in clinical symptoms) of venlafaxine (or another antidepressant if venlafaxine is not clinically indicated for a particular patient) are predictive of later clinical response.

Timeline

Start
1996-11
Primary completion
1996-11
Completion
1998-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Venlafaxine Small molecule 150 mg